Cantor Fitzgerald and other analyst firms issued ratings on Amgen stock, which is listed on the Nasdaq exchange.

The entities involved

• Amgen →

  American multinational biopharmaceutical company

  • Amgen announced results from the VESALIUS-CV trial, led by Duke and involving Harvard, at AHA's Scientific Sessions.06:18
  • Morgan Stanley and Citigroup raised price objectives on Amgen shares, with MarketBeat reporting the consensus rating.Wed 23:05
• Cantor Fitzgerald →

  American financial services company

  • Cantor Fitzgerald, Citigroup, and MarketBeat issued rating updates and price targets for Rigel Pharmaceuticals, Inc.08:59
  • Skydance Media received an overweight rating and a price objective raise, as reported by Benzinga and Cantor Fitzgerald.Tue 17:34
• Nasdaq →

  American fully electronic stock exchange

  • AMD stock is listed on Nasdaq, and financial institutions Truist Financial and HSBC have commented on the company's shares.13:32
  • Strong quarterly results and foreign fund inflows supported technology stocks and lifted investor sentiment across markets.10:05

Related events

• Amgen, Vertex, and Incyte shares traded on Nasdaq, and Robert A. Bradway leads Amgen's long-term growth strategy.Wed 22:56
• Novavax stock is trading on the Nasdaq electronic stock exchange, with company news and ratings being aggregated by MarketBeat.Jun 7
• HighPeak Energy, Inc. was listed on the Nasdaq electronic stock exchange and received buy/sell ratings from analysts on May 26, 2026.Jun 7
• MarketBeat is reporting on consensus ratings for Aehr Test Systems, a company whose stock trades on the Nasdaq exchange.Aug 15
• Arrive AI traded on the Nasdaq stock exchange, with its performance covered by financial blog MarketBeat.Aug 30